Cargando…
M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
BACKGROUND: Clozapine remains the only antipsychotic with unique efficacy in treatment resistant schizophrenia (TRS). Considerable ongoing research and clinical efforts have focused on reducing barriers to clozapine use in a bid to increase rates of clozapine use to improve outcomes in TRS. However,...
Autores principales: | Lee, Jimmy, Yin Yee, Jie, Mei See, Yuen, Tang, Charmaine, Tat Ng, Boon, Chowbay, Balram, Remington, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234398/ http://dx.doi.org/10.1093/schbul/sbaa030.527 |
Ejemplares similares
-
F224. UTILITY OF SALIVA FOR MONITORING OF CLOZAPINE LEVELS
por: Lee, Jimmy, et al.
Publicado: (2018) -
M60. EARLY VERSUS DELAYED PRESCRIPTION OF CLOZAPINE AND THE COGNITIVE PERFORMANCE ON SCHIZOPHRENIA
por: Amoretti, Silvia, et al.
Publicado: (2020) -
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Martini, Francesca, et al.
Publicado: (2020) -
M117. ELUCIDATING ARCHITECTURE OF NEGATIVE SYNDROME IN SCHIZOPHRENIA
por: San Ang, Mei, et al.
Publicado: (2020) -
M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)